JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Alexei, Laura | |
| dc.date.accessioned | 2020-09-22T06:28:44Z | |
| dc.date.available | 2020-09-22T06:28:44Z | |
| dc.date.issued | 2020 | |
| dc.identifier.citation | ALEXEI, Laura. Caffeine and paracetamol. In: MedEspera: the 8th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2020, p. 283-284. | en_US |
| dc.identifier.uri | https://repository.usmf.md/handle/20.500.12710/11718 | |
| dc.identifier.uri | https://medespera.asr.md/wp-content/uploads/ABSTRACT-BOOK.pdf | |
| dc.description | Departament of Pharmacology and Clinical Pharmacology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020 | en_US |
| dc.description.abstract | Introduction. The diverse commercial names for paracetamol and combinations of this drug are part of the OTC list and do not need a medical prescription. One of the compounds in these combinations is caffeine, which is considered to enhance the effects of non-opioid analgesics in symptomatic treatments or self-treatment of acute respiratory infections. Some patients use these drugs due to the caffeine found in them without the awareness of other components and their influence on the body. These circumstances could be responsible for acute intoxications and fatal side-effects (such as fulminant hepatic necrosis). | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | MedEspera | en_US |
| dc.subject | paracetamol | en_US |
| dc.subject | caffeine | en_US |
| dc.subject | analgesia | en_US |
| dc.title | Caffeine and paracetamol | en_US |
| dc.type | Article | en_US |
Files in this item
This item appears in the following Collection(s)
-
MedEspera 2020
The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020